Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Nutrinia Ltd Developer of an oral formulation of insulin for intestinal malabsorption in preterm newborns and SBS in infants. |
Israel | 18 Aug 2016 | Series D Initial investment. Round participant. Active |